Background and study aims: Previous attempts at assessing the safety of upper gastrointestinal endoscopy have been hampered by incomplete data collection. We aimed to assess the 30-day mortality associated with esophagogastroduodenoscopy (EGD) and assess the important risk factors.
Patients and methods: A retrospective cohort study was conducted of patients who underwent endoscopy at Ninewells Hospital in Dundee between 1 June 2000 and 31 May 2003. A total of 11 501 EGDs were performed in 8926 patients. These patients were record-linked to the death registry and the database of hospital admissions in order to calculate the all-cause 30-day mortality. An expert panel judged whether EGD had caused or contributed to the deaths. Logistic regression analysis was performed on outcomes of all-cause and EGD-contributed mortality.
Results: The median age of the patients was 62 years (interquartile range 48 - 74 years), 54 % were women, and 94 % of procedures were diagnostic. A total of 395 patients died within 30 days (all-cause 30-day mortality rate 4.4 %). One patient death was caused directly by the EGD (procedure-caused mortality rate 1 in 9000). EGD was judged to have contributed to patient deaths at a rate of 1 in 182, based on majority agreement of experts: some factors associated with these deaths were percutaneous endoscopic gastrostomy insertion (odds ratio [OR] 18.39, 95 % confidence interval [CI] 5.71 - 59.22), melena or hematemesis indications (OR 9.01, 95 % CI 3.53 - 22.99), and esophageal varices (OR 6.28, 95 % CI 1.54 - 25.60).
Conclusions: A causal death rate of 1 in 9000 suggests that EGD is very safe. However, certain patient groups have an increased mortality, and the risks and benefits of EGD should be carefully evaluated in each patient.
References
1
Quine M A, Bell G D, McCloy R F. et al .
A prospective audit of upper gastrointestinal endoscopy in two regions of England: safety, staffing and sedation methods.
Gut.
1995;
36
462-467
2 Barlow D, Bell G D, Chalmers A H. et al. and UK Academy of Medical Royal Colleges and their Faculties .Implementing and ensuring safe sedation practice for healthcare procedures in adults: report of an intercollegiate working party chaired by the Royal College of Anaesthetists, 2001. Available from: http://www.rcoa.ac.uk/docs/safesedationpractice.pdf
4
Callahan C M, Haag K M, Weinberger M. et al .
Outcomes of percutaneous endoscopic gastrostomy among older adults in a community setting.
J Am Geriatr Soc.
2000;
48
1048-1054
5
Forbes R B, Colville S, Swingler R J. and the Scottish Motor Neurone Disease Research Group .
Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease - a record linkage study from the Scottish Motor Neurone Disease Register.
J Neurol.
2004;
251
813-817
6
Dennis M S, Lewis S C, Warlow C. et al .
Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial.
Lancet.
2005;
365
764-772
7 Clarke I, Dunnet C, Camp J. et al .Management of patients with stroke: identification and management of dysphagia. A national clinical guideline. Scottish Intercollegiate Guidelines Network (SIGN). Scotland: SIGN 2004
8
Evans J MM, McDevitt D G, MacDonald T M.
The Tayside Medicines Monitoring Unit (MEMO): a record-linkage system for pharmacovigilance.
Pharm Med.
1995;
9
177-184
9
Light V L, Slezak F A, Porter J A. et al .
Predictive factors for early mortality after percutaneous endoscopic gastrostomy.
Gastrointest Endosc.
1995;
42
330-335
10
Bourdel-Marchasson I, Dumas F, Pinganaud G. et al .
Audit of percutaneous endoscopic gastrostomy in long-term enteral feeding in a nursing home.
Int J Qual Health Care.
1997;
9
297-302
11
Onishi J, Kuzuya M, Sakaguchi H.
Survival rate alter percutaneous endoscopic gastrostomy in a long-term care hospital [letter].
Clin Nutr.
2004;
23
1248-1249
